Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
European Journal of Cancer,  Clinical Article

Keizman D et al. – Bisphosphonates may improve the RR, PFS and OS of sunitinib treatment in RCC with bone metastases.

Methods

  • A multicentre retrospective study of patients with bone metastases from RCC treated with sunitinib was conducted.
  • The effect of bisphosphonates on RR, PFS and OS was tested with adjustment for known prognostic factors.

Results
  • Between 2004 and 2011, 209 patients with metastatic RCC were treated with sunitinib, 76 had bone metastases, 35 bisphosphonates users and 41 non-users.
  • Objective response was partial response/stable disease 86% (n=30) versus 71% (n=29), and progressive disease 14% (n=5) versus 29% (n=12) (p=0.125, OR 2.48) in users versus non-users, respectively.
  • Median PFS was 15 versus 5 months (HR=0.55, p<0.0001), and median OS was not reached (with a median follow-up time of 45months) versus 14months (HR=0.4, p=0.029), in favour of users.
  • In multivariate analysis of the entire patient cohort (n=76), factors associated with PFS were bisphosphonates use (HR=0.58, p=0.035), and pre-treatment neutrophil to lymphocyte ratio >3 (HR=3.5, p=0.009).
  • Factors associated with OS were bisphosphonates use (HR=0.5, p=0.008), elevated pre-treatment alkaline phosphatase (HR=2.9, p=0.003) and sunitinib induced HTN (HR=0.63, p<0.0001).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

2 ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010 American Journal of Kidney Diseases, August 18, 2014    Clinical Article

3 Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients Therapeutic Apheresis and Dialysis, September 15, 2014    Clinical Article

4 Hypertension: Fluid overload and post-dialysis hypertension Nature Reviews Nephrology, September 25, 2014    Review Article

5 Ultrasonography versus computed tomography for suspected nephrolithiasis New England Journal of Medicine, September 19, 2014    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

6 Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study The Journal of Clinical Hypertension, July 23, 2014    Clinical Article

7 Vancomycin-resistant enterococci colonization among dialysis patients: A meta-analysis of prevalence, risk factors, and significance American Journal of Kidney Diseases, July 18, 2014    Review Article

8 Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization The American Journal of Cardiology, September 5, 2014    Evidence Based Medicine    Review Article    Clinical Article

9 Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies Nephrology Dialysis Transplantation, August 28, 2014    Evidence Based Medicine    Review Article

10 Meta-analysis of the effect of statins on renal function The American Journal of Cardiology, August 7, 2014    Evidence Based Medicine    Review Article    Clinical Article

11 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

12 Association of kidney function and albuminuria with prevalent and incident hypertension: The atherosclerosis risk in communities (ARIC) study American Journal of Kidney Diseases, August 22, 2014    Clinical Article

13 The role of statins in preventing contrast-induced acute kidney injury: a narrative review Angiology, September 17, 2014    Review Article    Clinical Article

14 Daily protein intake and patient outcomes in severe acute kidney injury: Findings of the randomized evaluation of normal versus augmented level of replacement therapy (RENAL) trial Blood Purification, September 4, 2014    Clinical Article

15 Improving clinical outcomes among hemodialysis patients: A proposal for a volume first approach from the chief medical officers of US dialysis providers American Journal of Kidney Diseases, August 25, 2014    Clinical Article

16 Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal disease European Journal of Neurology, September 12, 2014    Review Article

17 A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial American Journal of Kidney Diseases, August 11, 2014    Clinical Article

18 Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis Arthritis Care & Research , September 24, 2014    Clinical Article

19 Comparison of risk of acute kidney injury following primary percutaneous coronary interventions with the transradial approach vs the transfemoral approach (from the PRIPITENA urban registry) The American Journal of Cardiology, September 16, 2014    Clinical Article

20 The case for 0.9% NaCl: Is the undefendable, defensible? Kidney International, July 22, 2014

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close